by Barry101 | May 24, 2016 | Press Release
PHILADELPHIA, May 24, 2016 — Hemispherx Biopharma (NYSE MKT:HEB) announced today that it has executed an amended and restated agreement with Impatients, N.V., a Netherlands based company doing business as myTomorrows, for the commencement and management of an...
by Barry101 | May 23, 2016 | Press Release
PHILADELPHIA, May 23, 2016 — Hemispherx Biopharma (NYSE MKT:HEB) announced today that it has executed an amended and restated agreement with Impatients, N.V., a Netherlands based company doing business as myTomorrows, for the commencement and management of an...
by Barry101 | May 16, 2016 | Press Release
The company is now focusing on commercial success by seeking co-development partners and working closely with the research and regulatory communities to bring disease fighting technologies to the world.Conference Call Scheduled for Tuesday, May 17, 2016 at 1:00 PM...
by Barry101 | May 12, 2016 | Press Release
PHILADELPHIA, May 12, 2016 — Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the “Company” or “Hemispherx”) announced today that it anticipates filing its 2016 first quarter financial results for quarter ended March 31 on Monday, May 16,...
by Barry101 | Apr 20, 2016 | Press Release
PHILADELPHIA, April 20, 2016 — Hemispherx Biopharma (NYSE MKT:HEB) (the “Company” or “Hemispherx”) announced that it has signed a consulting agreement with Huron Consulting Group, a global consultancy with decades of experience in the...
by Barry101 | Apr 4, 2016 | Press Release
PHILADELPHIA, April 04, 2016 — Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the Company) announced today that it has entered into a Clinical Trial, Sales, Marketing, Distribution, and Supply Agreement with Scientific Products Pharmaceutical Co. LTD (SCIEN) located...
